Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Subspecialties Glaucoma, Cataract, Business and Innovation, Practice Management

Glaucoma Management: Infinitely Improved

sponsored by Glaukos

Glaukos founded the MIGS category 20 years ago with the first generation iStent. Continuous innovation since then has resulted in a device portfolio that has revolutionized glaucoma management. With two decades of studies behind it, the iStent platform has the longest-term body of evidence of any MIGS procedure: its safety and efficacy are evident in 200+ peer-reviewed publications – setting the device apart from others.

Given the short learning curve of the iStent inject® W and its broad compatibility with other procedures – including advanced IOL implantation – this device is the first choice for mild-tomoderate glaucoma management. And now, iStent infinite, the latest manifestation of Glaukos’ ground-breaking technology, is designed to provide
surgeons the first standalone, non-ablative MIGS device for patients in need.

Download the supplement


Ike K. Ahmed, Assistant Professor, Director, Glaucoma & Advanced Anterior Segment Surgery (GAAS) Fellowship, Research Director, Kensington Eye Institute, University of Toronto; Clinical Professor, University of Utah; Director, Division Head, Ophthalmology, Trillium Health Partners, Mississauga; Medical Director, Prism Eye Institute, Mississauga; Co-Medical Director, TLC Mississauga, Ontario, Canada

Christophe Baudouin, Professor of Ophthalmology, chairing the department at Quinze-Vingts National Ophthalmology Hospital in Paris, France

Mark Gallardo, surgeon at El Paso Eye Surgeons, and Adjunct Professor, University of Texas Health Sciences Centre, Houston, Texas, USA

Fritz Hengerer, Director and Chief Medical Officer at the Department of Ophthalmology at Buergerhospital Eye Clinic in Frankfurt, Germany

Leon Walker Herndon, Professor of Ophthalmology, Chief of Glaucoma Division, Duke ophthalmology, Duke University School of Medicine, Durham, North Carolina, USA

Alex Huang, Associate Professor, Alfred Vogt Chair in Ophthalmology at the Shiley Eye Institute, University of California, San Diego, USA

Karsten Klabe, ophthalmic surgeon at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany

Eva Liang, refractive surgeon at Center for Sight, Las Vegas, Nevada, USA

Deborah Ristvedt, ophthalmic surgeon at Vance Thompson Vision, Bozeman, Montana, USA

Thomas Samuelson, founding partner and attending surgeon at Minnesota Eye Consultants, and Adjunct Professor, University of Minnesota, Bloomington, Minnesota, USA

Mitch Shultz, ophthalmic surgeon at Shultz Chang, Northridge, California, USA

Paul Singh, President of The Eye Centers of Racine & Kenosha, Wisconsin, USA

Blake K. Williamson, ophthalmic surgeon at the Williamson Eye Center, Baton Rouge, Louisiana, USA

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Case Study
Finding Ocular Surface Inflammation

| Contributed by Quidel

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine